Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2021

Open Access 01-12-2021 | Cancer Fatigue | Correction

Correction to: Bridging the research to practice gap: a systematic scoping review of implementation of interventions for cancer-related fatigue management

Authors: Oluwaseyifunmi Andi Agbejule, Nicolas H. Hart, Stuart Ekberg, Bogda Koczwara, Rahul Ladwa, Camilla Simonsen, Elizabeth P. Pinkham, Raymond Javan Chan

Published in: BMC Cancer | Issue 1/2021

Login to get access

Excerpt

Correction to: BMC Cancer 21, 809 (2021) …
Literature
1.
Agbejule OA, Hart NH, Ekberg S, Koczwara B, Ladwa R, Simonsen C, et al. Bridging the research to practice gap: a systematic scoping review of implementation of interventions for cancer-related fatigue management. BMC Cancer. 2021;21(1):809. https://​doi.​org/​10.​1186/​s12885-021-08394-3.
Metadata
Title
Correction to: Bridging the research to practice gap: a systematic scoping review of implementation of interventions for cancer-related fatigue management
Authors
Oluwaseyifunmi Andi Agbejule
Nicolas H. Hart
Stuart Ekberg
Bogda Koczwara
Rahul Ladwa
Camilla Simonsen
Elizabeth P. Pinkham
Raymond Javan Chan
Publication date
01-12-2021
Publisher
BioMed Central
Keyword
Cancer Fatigue
Published in
BMC Cancer / Issue 1/2021
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-021-08619-5

Other articles of this Issue 1/2021

BMC Cancer 1/2021 Go to the issue

Research article

Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer

Research

Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformatics

Correction

Correction to: High fascin-1 expression in colorectal cancer identifies patients at high risk for early disease recurrence and associated mortality

Study protocol

Investigating efficacy of “microbiota modulation of the gut-lung Axis” combined with chemotherapy in patients with advanced NSCLC: study protocol for a multicenter, prospective, double blind, placebo controlled, randomized trial

Research article

Role of palliative radiotherapy in bleeding control in patients with unresectable advanced gastric cancer

Research

Expression of CIB1 correlates with colorectal liver metastases but not with peritoneal carcinomatosis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits